0QF.F
Moderna, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
125.30
▲ 12.90 (11.48%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
111.00
Prev close
112.40
Day high
135.70
Day low
111.00
Volume
18.58K
Market cap
$50.02B
P/E (TTM)
—
52W range
19.26 – 151.14
Day trading desk
Gap from prior close
-1.25%
Prior close 112.40
VWAP
128.78
-2.71% from price
Relative volume
8.52×
Unusually busy
Session range
22.25%
111.00 – 135.70
Position in range
58%
Mid range
ATR (14D)
13.45
10.73% of price
Prior day high
143.20
PDH
Prior day low
110.10
PDL
Bid / ask spread
—
Quote not published
Session volume
18.23K
Avg 2.14K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+132.99%
+134.4%
1M
+149.70%
+146.0%
3M
+205.46%
+202.4%
6M
+191.02%
+180.0%
YTD
+370.61%
+358.3%
1Y
+443.01%
+423.0%
3Y
+19.38%
-54.8%
5Y
-67.33%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 0QF.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
29.21M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 6, 26 | BANCEL STEPHANE J Chief Executive Officer |
CONVERSION | 751.72K | $14.40M | Direct |
| Aug 5, 26 | BANCEL STEPHANE J Chief Executive Officer |
SELL | 499.25K | $28.72M | Direct |
| Jul 15, 26 | HOGE STEPHEN President |
SELL | 53.34K | $3.61M | Direct |
| Jul 15, 26 | HOGE STEPHEN President |
CONVERSION | 53.34K | $1.02M | Direct |
| Jul 2, 26 | MOCK JAMES M Chief Financial Officer |
— | 1.45K | — | Direct |
| Jun 15, 26 | HOGE STEPHEN President |
SELL | 53.34K | $2.74M | Direct |
| Jun 15, 26 | HOGE STEPHEN President |
CONVERSION | 53.34K | $1.02M | Direct |
| Jun 5, 26 | MOCK JAMES M Chief Financial Officer |
— | 11.80K | — | Direct |
| Jun 5, 26 | KLINGER SHANNON THYME Officer |
CONVERSION | 15.27K | $107.46K | Direct |
| Jun 4, 26 | KLINGER SHANNON THYME Officer |
SELL | 3.47K | $173.55K | Direct |
| Jun 1, 26 | HOGE STEPHEN President |
— | 9.28K | — | Direct |
| Jun 1, 26 | MOCK JAMES M Chief Financial Officer |
— | 2.48K | — | Direct |
| Jun 1, 26 | KLINGER SHANNON THYME Officer |
— | 2.17K | — | Direct |
| May 28, 26 | HOGE STEPHEN President |
— | 2.05K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AFEYAN NOUBAR BOGHOS |
Director | — | Sale |
BANCEL STEPHANE J |
Chief Executive Officer | 22.22M | Conversion of Exercise of derivative security |
HOGE STEPHEN |
President | 1.64M | Sale |
HORNING SANDRA |
Director | 18.59K | Conversion of Exercise of derivative security |
HUSSAIN SHAH ABBAS |
Director | 12.07K | Sale |
KLINGER SHANNON THYME |
Officer | 73.56K | Conversion of Exercise of derivative security |
MOCK JAMES M |
Chief Financial Officer | 66.44K | Conversion of Exercise of derivative security |
NABEL ELIZABETH G |
Director | 19.32K | Conversion of Exercise of derivative security |
NADER FRANCOIS E. |
Director | 32.78K | Conversion of Exercise of derivative security |
SAGAN PAUL L |
Director | — | Purchase |
Fundamentals
Market cap$50.02B
Enterprise value$46.17B
Revenue (TTM)$2.23B
Gross profit$-1.47B
EBITDA$-2.20B
Net income$-3.15B
EPS (TTM)$-6.83
Free cash flow$299.25M
Total cash$5.14B
Total debt$1.29B
Book value / share$14.50
Shares outstanding399.24M
Float372.27M
Short % of float—
Dividend yield—
Beta (5Y)0.90
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book8.64
EV / revenue20.72
EV / EBITDA-21.04
Gross margin-66.02%
Operating margin-557.93%
Profit margin-141.43%
Return on equity-39.00%
Return on assets-13.26%
Debt / equity19.04
Current ratio2.30
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.92B | $3.20B | $6.75B | $18.88B | -39.9% |
| Operating revenue | $3.30B | $4.52B | $8.20B | $18.43B | -26.9% |
| Cost of revenue | $868.00M | $1.46B | $4.69B | $5.42B | -40.7% |
| Gross profit | $1.05B | $1.74B | $2.06B | $13.46B | -39.3% |
| Research & development | $3.13B | $4.54B | $4.84B | $3.29B | -31.1% |
| Selling, general & admin | $1.02B | $1.17B | $1.55B | $1.13B | -13.3% |
| Total operating expense | $4.13B | $5.68B | $6.30B | $4.04B | -27.3% |
| Operating income | -$3.07B | -$3.94B | -$4.24B | $9.42B | +22.1% |
| Net interest income | $304.00M | $401.00M | $421.00M | $200.00M | -24.2% |
| Pre-tax income | -$2.77B | -$3.61B | -$3.94B | $9.57B | +23.3% |
| Tax provision | $54.00M | -$46.00M | $772.00M | $1.21B | +217.4% |
| Net income | -$2.82B | -$3.56B | -$4.71B | $8.36B | +20.8% |
| Net income to common | -$2.82B | -$3.56B | -$4.71B | $8.36B | +20.8% |
| Basic EPS | -7.26 | -9.28 | -12.33 | 21.26 | +21.8% |
| Diluted EPS | -7.26 | -9.28 | -12.33 | 20.12 | +21.8% |
| EBIT | -$2.76B | -$3.58B | -$4.24B | $9.42B | +23.0% |
| EBITDA | -$2.54B | -$3.39B | -$3.62B | $9.77B | +25.1% |
| Basic shares | 389.00M | 384.00M | 382.00M | 394.00M | +1.3% |
| Diluted shares | 389.00M | 384.00M | 382.00M | 416.00M | +1.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.60B | $1.93B | $2.91B | $3.21B | +34.7% |
| Cash & short-term investments | $5.80B | $7.03B | $8.60B | $9.90B | -17.5% |
| Accounts receivable | $184.00M | $358.00M | $892.00M | $1.39B | -48.6% |
| Inventory | $153.00M | $117.00M | $202.00M | $949.00M | +30.8% |
| Total current assets | $6.54B | $8.10B | $10.32B | $13.43B | -19.2% |
| Property, plant & equipment | $2.85B | $2.96B | $2.66B | $2.14B | -3.5% |
| Goodwill & intangibles | $97.00M | $92.00M | $96.00M | $0 | +5.4% |
| Total assets | $12.34B | $14.14B | $18.43B | $25.86B | -12.8% |
| Total current liabilities | $1.99B | $2.21B | $3.02B | $4.92B | -9.9% |
| Long-term debt | $590.00M | — | — | — | — |
| Total debt | $1.30B | $747.00M | $1.24B | $1.20B | +74.7% |
| Total liabilities | $3.69B | $3.24B | $4.57B | $6.74B | +13.8% |
| Retained earnings | $7.22B | $10.04B | $13.61B | $18.32B | -28.1% |
| Shareholder equity | $8.65B | $10.90B | $13.85B | $19.12B | -20.6% |
| Working capital | $4.56B | $5.89B | $7.31B | $8.51B | -22.7% |
| Net tangible assets | $8.55B | $10.81B | $13.76B | $19.12B | -20.9% |
| Shares issued | 394.00M | 386.00M | 382.00M | 385.00M | +2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$2.82B | -$3.56B | -$4.71B | $8.36B | — | +20.8% |
| Depreciation & amortisation | $215.00M | $189.00M | $621.00M | $348.00M | — | +13.8% |
| Stock-based compensation | $483.00M | $429.00M | $305.00M | $226.00M | — | +12.6% |
| Change in working capital | $233.00M | -$78.00M | $689.00M | -$4.01B | — | +398.7% |
| Operating cash flow | -$1.87B | -$3.00B | -$3.12B | $4.98B | — | +37.6% |
| Capital expenditure | -$202.00M | -$1.05B | -$707.00M | -$400.00M | — | +80.8% |
| Investing cash flow | $1.95B | $1.95B | $4.21B | -$5.18B | — | -0.2% |
| Share buybacks | — | $0 | -$1.15B | -$3.33B | -$857.00M | — |
| Financing cash flow | $593.00M | $56.00M | -$1.38B | -$3.45B | — | +958.9% |
| Free cash flow | -$2.08B | -$4.05B | -$3.83B | $4.58B | — | +48.8% |
| End cash position | $2.60B | $1.93B | $2.93B | $3.22B | — | +34.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $143.00M | $389.00M | $676.00M | $1.00B | $137.00M | — | -63.2% |
| Operating revenue | $122.00M | $350.00M | $1.05B | $1.97B | $176.00M | — | -65.1% |
| Cost of revenue | $93.00M | $955.00M | $452.00M | $207.00M | $119.00M | — | -90.3% |
| Gross profit | $50.00M | -$566.00M | $224.00M | $795.00M | $18.00M | — | +108.8% |
| Research & development | $651.00M | $649.00M | $775.00M | $801.00M | $700.00M | — | +0.3% |
| Selling, general & admin | $216.00M | $173.00M | $308.00M | $268.00M | $230.00M | — | +24.9% |
| Total operating expense | $865.00M | $822.00M | $1.08B | $1.05B | $925.00M | — | +5.2% |
| Operating income | -$815.00M | -$1.39B | -$857.00M | -$260.00M | -$907.00M | — | +41.3% |
| Net interest income | $50.00M | $55.00M | $62.00M | $73.00M | $80.00M | — | -9.1% |
| Pre-tax income | -$767.00M | -$1.33B | -$799.00M | -$187.00M | -$818.00M | — | +42.5% |
| Tax provision | $15.00M | $9.00M | $27.00M | $13.00M | $7.00M | — | +66.7% |
| Net income | -$782.00M | -$1.34B | -$826.00M | -$200.00M | -$825.00M | — | +41.8% |
| Net income to common | -$782.00M | -$1.34B | -$826.00M | -$200.00M | -$825.00M | — | +41.8% |
| Basic EPS | -1.97 | -3.40 | -2.11 | — | -2.13 | -2.52 | +42.1% |
| Diluted EPS | -1.97 | -3.40 | -2.11 | — | -2.13 | -2.52 | +42.1% |
| EBIT | -$750.00M | -$1.32B | -$791.00M | -$187.00M | -$817.00M | — | +43.1% |
| EBITDA | -$687.00M | -$1.26B | -$724.00M | -$135.00M | -$760.00M | — | +45.4% |
| Basic shares | 398.00M | 395.00M | 392.00M | — | 388.00M | 386.00M | +0.8% |
| Diluted shares | 398.00M | 395.00M | 392.00M | — | 388.00M | 386.00M | +0.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.72B | $1.91B | $2.60B | $1.13B | $1.28B | -9.7% |
| Cash & short-term investments | $5.14B | $5.21B | $5.80B | $4.50B | $5.13B | -1.3% |
| Accounts receivable | $17.00M | $71.00M | $184.00M | $1.05B | $36.00M | -76.1% |
| Inventory | $280.00M | $146.00M | $153.00M | $332.00M | $240.00M | +91.8% |
| Total current assets | $5.82B | $5.77B | $6.54B | $6.60B | $6.17B | +0.8% |
| Property, plant & equipment | $2.76B | $2.79B | $2.85B | $2.86B | $2.92B | -1.3% |
| Goodwill & intangibles | $161.00M | $168.00M | $97.00M | $99.00M | $100.00M | -4.2% |
| Total assets | $10.96B | $11.49B | $12.34B | $12.13B | $12.01B | -4.6% |
| Total current liabilities | $2.53B | $2.40B | $1.99B | $1.68B | $1.57B | +5.8% |
| Long-term debt | $591.00M | $590.00M | $590.00M | — | — | +0.2% |
| Total debt | $1.29B | $1.30B | $1.30B | $734.00M | $741.00M | -0.8% |
| Total liabilities | $4.20B | $4.08B | $3.69B | $2.81B | $2.61B | +2.9% |
| Retained earnings | $5.10B | $5.88B | $7.22B | $8.05B | $8.25B | -13.3% |
| Shareholder equity | $6.76B | $7.41B | $8.65B | $9.33B | $9.40B | -8.7% |
| Working capital | $3.28B | $3.38B | $4.56B | $4.92B | $4.60B | -2.8% |
| Net tangible assets | $6.60B | $7.24B | $8.55B | $9.23B | $9.30B | -8.8% |
| Shares issued | 399.00M | 396.59M | 394.00M | 390.58M | 389.00M | +0.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$782.00M | -$1.34B | -$826.00M | -$200.00M | -$825.00M | — | +41.8% |
| Depreciation & amortisation | $63.00M | $59.00M | $67.00M | $52.00M | $57.00M | — | +6.8% |
| Stock-based compensation | $120.00M | $104.00M | $113.00M | $125.00M | $130.00M | — | +15.4% |
| Change in working capital | $79.00M | $553.00M | $1.56B | -$818.00M | -$297.00M | — | -85.7% |
| Operating cash flow | -$526.00M | -$630.00M | $930.00M | -$847.00M | -$919.00M | — | +16.5% |
| Capital expenditure | -$37.00M | -$62.00M | -$39.00M | -$33.00M | -$3.00M | — | +40.3% |
| Investing cash flow | $329.00M | -$76.00M | -$48.00M | $700.00M | $564.00M | — | +532.9% |
| Share buybacks | — | — | — | — | — | $0 | — |
| Financing cash flow | $14.00M | $17.00M | $581.00M | -$1.00M | $9.00M | — | -17.6% |
| Free cash flow | -$563.00M | -$692.00M | $891.00M | -$880.00M | -$922.00M | — | +18.6% |
| End cash position | $1.72B | $1.91B | $2.60B | $1.13B | $1.28B | — | -9.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $872.91M | -14.1% |
| Next quarter | — | — | $689.88M | +1.8% |
| Current year | — | — | $2.11B | +8.4% |
| Next year | — | — | $2.46B | +16.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders7.32%
Held by institutions80.46%
Institutions holding1.09K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
76.71
+63.35% from price
SMA 20
62.88
+99.28% from price
SMA 50
59.69
+109.92% from price
SMA 100
51.04
+145.48% from price
SMA 200
42.28
+196.36% from price
EMA 12
82.70
+51.52% from price
EMA 26
68.57
+82.73% from price
EMA 50
60.86
+105.89% from price
RSI (14)
70.5
Overbought
MACD (12,26,9)
14.13
Hist 8.83
ATR (14)
13.45
10.73% of price
Realised vol 30D
311.5%
Annualised
Bollinger upper
120.55
20, 2σ
Bollinger lower
5.20
20, 2σ
50 / 200 cross
Golden
59.69 vs 42.28
Trend bias
Above 200
+196.36%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.57
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
311.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-34.6%
Peak to trough
Max drawdown 5Y
-95.0%
Peak to trough
ATR 14
13.45
10.73% of price
Beta (reported)
0.90
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 21, 26 | JP Morgan | MAINTAINED | Underweight | Underweight |
| Aug 20, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Aug 20, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Aug 20, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 19, 26 | William Blair | UPGRADE | Market Perform | Outperform |
| Aug 3, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 21, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Jul 8, 26 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 7, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jul 7, 26 | B of A Securities | MAINTAINED | Underperform | Underperform |
| Jun 26, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jun 8, 26 | B of A Securities | MAINTAINED | Underperform | Underperform |
Headlines
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 5m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 6m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 6m ago
Uber faces fine of nearly $1B over automated driver suspensions
TechCrunch · 15m ago
This Company Has Raised Its Dividend for 72 Straight Years. Almost Nobody Talks About It.
Motley Fool · 17m ago
This Chinese Tech Giant Quietly Cut Its Buyback 80% to Fund AI
24/7 Wall St. · 27m ago
Look Back: Long before Party on the Patio, Mötley Crüe rocked Pocono Downs
The Times-Leader (Wilkes-Barre, Pa.) · 28m ago
Prediction: ExxonMobil Raises Its Dividend More Than Wall Street Expects
Motley Fool · 29m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.